首页> BMC gastroenterology> Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease.

Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease.

导出 OA

翻译打印收藏纠错

第一作者： Yunfei,Wu

第一单位： Department of Pathology, Changzhou Third People's Hospital, Changzhou, 213001, China.

作者： Yunfei,Wu ^[1] ; Yan,Han ^[2] ; Liming,Zheng ^[3] ; Longgen,Liu ^[4] ; Wenjian,Li ^[5] ; Fan,Zhang ^[6]

作者单位： Department of Pathology, Changzhou Third People's Hospital, Changzhou, 213001, China. ^[1] Department of Endocrinology, Changzhou Third People's Hospital, Changzhou, 213001, China.;Department of Clinical Nutrition, Changzhou Third People's Hospital, Changzhou, 213001, China. ^[2] Clinical Laboratory, Changzhou Third People's Hospital, Changzhou, 213001, China. ^[3] Department of Liver Diseases, Changzhou Third People's Hospital, Changzhou, 213001, China. ^[4] Department of Urology, Changzhou Third People's Hospital, Changzhou, 213001, China. bolite@163.com.;Changzhou Medical Center, Nanjing Medical University, Changzhou, 213001, China. bolite@163.com. ^[5] Department of Endocrinology, Changzhou Third People's Hospital, Changzhou, 213001, China. yifan52518@163.com.;Department of Clinical Nutrition, Changzhou Third People's Hospital, Changzhou, 213001, China. yifan52518@163.com.;Changzhou Medical Center, Nanjing Medical University, Changzhou, 213001, China. yifan52518@163.com. ^[6]

关键词 AcFibroMASH index At-risk MASH Liver biopsy Metabolic dysfunction-associated steatotic liver disease Significant liver fibrosis